Cell-mediated Immunity Against Herpes Simplex Virus Envelope, Capsid, Excreted, and Crude Antigens

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 1983 Jan 1

PMID 6295957

Citations 6

Authors

K O Kalimo

I A Joronen

V K Havu

Affiliations

Soon will be listed here.

Abstract

Cell-mediated immunity to herpes simplex virus envelope, capsid, excreted, and crude antigens was studied by in vitro lymphocyte stimulation tests during 198 recurrent attacks in 69 patients. Excreted antigen caused no blast transformation. Envelope and capsid antigen-induced lymphocyte stimulation was at the maximum 7 to 14 days postinfection, declining thereafter to a rather constant level in 1 to 2 months. The lowest levels were measured just a few days before a new attack. In persons with frequent relapses, the fluctuation was more rapid and stimulation index levels stayed higher, although no protective level seemed to exist. Cultures stimulated with the crude antigen in autologous serum showed rapid increases and declines in the stimulation index values, contrary to those grown in agamma serum, in which the stimulation level stayed rather constant up to 1 year postinfection.

Citing Articles

Association between HSV1 seropositivity and obesity: data from the National Health and Nutritional Examination Survey, 2007-2008.

Karjala Z, Neal D, Rohrer J PLoS One. 2011; 6(5):e19092.

PMID: 21589933 PMC: 3092767. DOI: 10.1371/journal.pone.0019092.

Recent progress in herpes simplex virus immunobiology and vaccine research.

Koelle D, Corey L Clin Microbiol Rev. 2003; 16(1):96-113.

PMID: 12525427 PMC: 145296. DOI: 10.1128/CMR.16.1.96-113.2003.

CD4 T-cell responses to herpes simplex virus type 2 major capsid protein VP5: comparison with responses to tegument and envelope glycoproteins.

Koelle D, Schomogyi M, McClurkan C, Reymond S, Chen H J Virol. 2000; 74(23):11422-5.

PMID: 11070045 PMC: 113250. DOI: 10.1128/jvi.74.23.11422-11425.2000.

Human immune responses to herpes simplex virus, varicella-zoster and cytomegalovirus in vitro.

Williamson S, Parish N, Chambers J, Knight R Immunology. 1986; 57(3):437-42.

PMID: 3007334 PMC: 1453829.

Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections.

Vestey J, Norval M, Howie S, Maingay J, Neill W Clin Exp Immunol. 1989; 77(3):384-90.

PMID: 2553308 PMC: 1542042.

References

Kaplan A, Erickson J, Ben-Porat T . Synthesis of proteins in cells infected with herpesvirus. X. Proteins excreted by cells infected with herpes simplex virus, types 1 and 2. Virology. 1975; 64(1):132-43. DOI: 10.1016/0042-6822(75)90085-9. View

Wybran J, Carr M, Fudenberg H . Effect of serum on human rosett-forming cells in fetuses and adult blood. Clin Immunol Immunopathol. 1973; 1(3):408-13. DOI: 10.1016/0090-1229(73)90057-3. View

Thong Y, VINCENT M, Hensen S, FUCCILLO D, Rola-Pleszczynski M, Bellanti J . Depressed specific cell-mediated immunity to Herpes simplex virus type 1 in patients with recurrent herpes labialis. Infect Immun. 1975; 12(1):76-80. PMC: 415247. DOI: 10.1128/iai.12.1.76-80.1975. View

Gange R, De Bats A, Park J, BRADSTREET C, Rhodes E . Cellular immunity and circulating antibody to herpes simplex virus in subjects with recurrent herpex simplex lesions and controls as measured by the mixed leukocyte migration inhibition test and complement fixation. Br J Dermatol. 1975; 93(5):539-44. DOI: 10.1111/j.1365-2133.1975.tb02246.x. View

Kalimo K, Ziola B, Viljanen M, Granfors K, TOIVANEN P . Solid-phase radioimmunoassay of herpes simplex virus IgG and IgM antibodies. J Immunol Methods. 1977; 14(2):183-95. DOI: 10.1016/0022-1759(77)90008-4. View

OReilly R, Chibbaro A, Anger E, Lopez C . Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis. J Immunol. 1977; 118(3):1095-1102. View

Kalimo K, Marttila R, Granfors K, Viljanen M . Solid-phase radioimmunoassay of human immunoglobulin M and immunoglobulin G antibodies against herpes simplex virus type 1 capsid, envelope, and excreted antigens. Infect Immun. 1977; 15(3):883-9. PMC: 421456. DOI: 10.1128/iai.15.3.883-889.1977. View

Shillitoe E, Wilton J, Lehner T . Sequential changes in cell-mediated immune responses to herpes simplex virus after recurrent herpetic infection in humans. Infect Immun. 1977; 18(1):130-7. PMC: 421204. DOI: 10.1128/iai.18.1.130-137.1977. View

Kirchner H, Schwenteck M, Northoff H, Schopf E . Defective in vitro lymphoproliferative responses to herpes simplex virus in patients with frequently recurring herpes infections during the disease-free interval. Clin Immunol Immunopathol. 1978; 11(3):267-74. DOI: 10.1016/0090-1229(78)90050-8. View

10.

Moller-Larsen A, Haahr S, Black F . Cellular and humoral immune responses to herpes simplex virus during and after primary gingivostomatitis. Infect Immun. 1978; 22(2):445-51. PMC: 422177. DOI: 10.1128/iai.22.2.445-451.1978. View

11.

Pettersson D, Mellstedt H, Holm G . IgG on human blood lymphocytes studied by immunofluorescence. Scand J Immunol. 1978; 8(6):535-42. DOI: 10.1111/j.1365-3083.1978.tb00553.x. View

12.

Shore S, Cromeans T, Norrild B . Early damage of herpes-infected cells by antibody-dependent cellular cytotoxicity: relative roles of virus-specified cell-surface antigens and input virus. J Immunol. 1979; 123(5):2239-44. View

13.

Pelton B, Duncan I, DENMAN A . Herpes simplex virus depresses antibody production by affecting T-cell function. Nature. 1980; 284(5752):176-7. DOI: 10.1038/284176a0. View

14.

Norrild B, Shore S, Cromeans T, Nahmias A . Participation of three major glycoprotein antigens of herpes simplex virus type 1 early in the infectious cycle as determined by antibody-dependent cell-mediated cytotoxicity. Infect Immun. 1980; 28(1):38-44. PMC: 550890. DOI: 10.1128/iai.28.1.38-44.1980. View

15.

Lawman M, Courtney R, Eberle R, Schaffer P, OHara M, Rouse B . Cell-mediated immunity to herpes simplex virus: specificity of cytotoxic T cells. Infect Immun. 1980; 30(2):451-61. PMC: 551334. DOI: 10.1128/iai.30.2.451-461.1980. View

16.

Boyum A . A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. General sedimentation properties of white blood cells in a 1g gravity field. Scand J Clin Lab Invest Suppl. 1968; 97:51-76. View

17.

Neff J, ENDERS J . Poliovirus replication and cytopathogenicity in monolayer hamster cell cultures fused with beta propiolactone-inactivated Sendai virus. Proc Soc Exp Biol Med. 1968; 127(1):260-7. DOI: 10.3181/00379727-127-32668. View

18.

Czarnetzki B, Macher E . In vitro studies on the human cellular immune response to commercially available herpes simplex antigens. Arch Dermatol Res. 1980; 268(3):247-55. DOI: 10.1007/BF00404285. View

19.

DOUGLAS Jr R, Couch R . A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans. J Immunol. 1970; 104(2):289-95. View

20.

Oppenheim J . Modulation of in vitro lymphocyte transformation by antibodies: enhancement by antigen-antibody complexes and inhibition by antibody excess. Cell Immunol. 1972; 3(3):341-60. DOI: 10.1016/0008-8749(72)90243-2. View